Cefazolin Sodium
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | IV or IM | 20-25 mg/kg | q8h | Duration: Varies with infection; typically 5-7 days Notes: For surgical prophylaxis: administer 20 mg/kg IV at induction, repeat every 90 minutes during surgery if needed. |
| Cat | IV or IM | 20-25 mg/kg | q8h | Duration: Varies with infection; typically 5-7 days Notes: For surgical prophylaxis: administer 20 mg/kg IV at induction, repeat every 90 minutes during surgery if needed. |
| Horse | IV or IM | 10-20 mg/kg | q6-8h | Duration: Varies with infection; typically 5-7 days Notes: For surgical prophylaxis: administer 10-20 mg/kg IV at induction, repeat every 2 hours during surgery if needed. |
| Cattle | IV or IM | 10-20 mg/kg | q8-12h | Duration: Varies with infection; typically 3-5 days Notes: Not commonly used in cattle; consider withdrawal times. For surgical prophylaxis: administer 10-20 mg/kg IV at induction. |
| Small Ruminants (sheep, goats) | IV or IM | 10-20 mg/kg | q8-12h | Duration: Varies with infection; typically 3-5 days Notes: Not commonly used in food animals; consider withdrawal times. |
| Rabbit | IV or IM | 20 mg/kg | q8-12h | Duration: Varies with infection; typically 5-7 days Notes: Use cautiously in rabbits due to potential GI disturbances. |
| Birds/Poultry | IM | 50-100 mg/kg | q8-12h | Duration: Varies with infection; typically 3-5 days Notes: Not commonly used in poultry; consider withdrawal times. |
| Exotic/Other (reptiles, small mammals) | IM or IV | 20-50 mg/kg | q12-24h | Duration: Varies with infection Notes: Dose based on species and clinical judgment; off-label use. |
Clinical Indications & Species Uses
- Perioperative prophylaxis for surgical procedures to reduce the risk of surgical site infections.
- Treatment of susceptible bacterial infections: skin and soft tissue infections, urinary tract infections, respiratory tract infections, bone and joint infections, septicemia, and surgical prophylaxis.
- Treatment of susceptible bacterial infections: skin and soft tissue infections, urinary tract infections, respiratory tract infections, and surgical prophylaxis.
- Treatment of susceptible bacterial infections: respiratory tract infections, skin and soft tissue infections, septic arthritis, and surgical prophylaxis.
- Treatment of susceptible bacterial infections: respiratory tract infections, skin infections, and surgical prophylaxis.
- Treatment of susceptible bacterial infections in reptiles, small mammals, and other exotic species (off-label use).
Pharmacology & Mechanism of Action
Drug Class: Cephalosporin antibiotic | Pharmacological Group: First-generation cephalosporin
Mechanism of Action: Cefazolin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby disrupting peptidoglycan cross-linking. This leads to cell wall weakening, osmotic instability, and ultimately bacterial lysis. It is bactericidal against susceptible organisms.
Pharmacodynamics: Cefazolin exhibits time-dependent killing, with efficacy correlated with the duration of time that serum concentrations exceed the minimum inhibitory concentration (MIC) of the pathogen. It is active against many gram-positive cocci (e.g., Staphylococcus spp., Streptococcus spp.) and some gram-negative organisms (e.g., Escherichia coli, Klebsiella spp.). It is not effective against methicillin-resistant staphylococci, Enterococcus spp., Pseudomonas aeruginosa, or anaerobes like Bacteroides fragilis.
β‘ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Known hypersensitivity to cephalosporins or other beta-lactam antibiotics.
- History of anaphylactic reactions to penicillins (cross-reactivity possible).
- Use in animals with severe renal impairment without dose adjustment.
- Use with caution in animals with a history of allergic reactions to penicillins or other cephalosporins.
- Dose adjustment may be necessary in animals with renal insufficiency.
- Prolonged use may result in overgrowth of non-susceptible organisms (e.g., Candida, Clostridium difficile).
- In food animals, observe withdrawal times to avoid violative residues.
- Intramuscular injections may cause pain and tissue irritation; administer deeply into a large muscle mass.
- Rapid IV administration may cause nausea, vomiting, or hypotension; infuse slowly.
Adverse Effects & Reactions
Common:
- Pain at injection site
- Swelling at injection site
- Gastrointestinal upset (nausea, vomiting, diarrhea) in some species
Serious / Severe:
- Anaphylaxis (rare but potentially fatal)
- Acute renal injury (especially with high doses or in dehydrated animals)
- Clostridium difficile-associated diarrhea (prolonged use)
- Seizures (with very high doses or in renal failure)
Rare:
- Blood dyscrasias (neutropenia, thrombocytopenia)
- Hepatotoxicity
- Interstitial nephritis
- Superinfections
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Aminoglycosides (e.g., gentamicin, amikacin) | Additive nephrotoxicity; increased risk of renal damage. | High |
| Loop diuretics (e.g., furosemide) | Increased risk of nephrotoxicity. | Moderate |
| Probenecid | Decreases renal tubular secretion of cefazolin, increasing its serum concentration and duration of action. | Moderate |
| Warfarin and other anticoagulants | Cephalosporins may enhance the effect of anticoagulants by interfering with vitamin K metabolism. | Moderate |
| Bacteriostatic antibiotics (e.g., tetracyclines, macrolides) | Potential antagonism of bactericidal activity; avoid concurrent use. | Moderate |
Overdose & Toxicity Management
Signs of Toxicity:
- Seizures
- Neurological signs (muscle twitching, tremors)
- Nausea and vomiting
- Diarrhea
- Acute renal failure (with very high doses)
Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. In cases of recent oral ingestion (though rare), consider gastric lavage or activated charcoal. For parenteral overdose, monitor renal function and provide fluid therapy to enhance elimination. In severe cases, hemodialysis may be considered. Anticonvulsants (e.g., diazepam) may be used to control seizures.
Food Animal Withdrawal Times
Withdrawal times are not established for all species; consult regulatory guidelines. For cattle, meat withdrawal is 4 days and milk withdrawal is 96 hours. For sheep and goats, withdrawal times may vary; use extra-label with caution. Not approved for use in poultry in the US.
Storage, Handling & Regulatory Information
Storage Temperature: Store powder at room temperature (20-25Β°C). Reconstituted solution is stable for 24 hours at room temperature and 96 hours under refrigeration (2-8Β°C).
Handling & Special Conditions: Protect from freezing. Discard unused reconstituted solution after the stated time.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Approved for use in dogs, cats, and horses. Not approved for food animals in the US, but may be used extra-label.
Extra-Label (Off-Label) Use: In the US, extra-label use in food animals is permitted under AMDUCA with a valid veterinary-client-patient relationship, but requires extended withdrawal times. Consult FARAD for specific withdrawal recommendations.
Clinical Pearls & Practice Notes
References & Literature
- π Plumb's Veterinary Drug Handbook
- π Papich Veterinary Pharmacology and Therapeutics
- π Compendium of Veterinary Products (CVP)